Terms: = Pancreatic cancer AND QKI, Hqk, 9444, ENSG00000112531, Q96PU8, QK3, DKFZp586I0923, QK AND Prognosis
2 results:
1. An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.
Ruta V; Naro C; Pieraccioli M; Leccese A; Archibugi L; Cesari E; Panzeri V; Allgöwer C; Arcidiacono PG; Falconi M; Carbone C; Tortora G; Borrelli F; Attili F; Spada C; Quero G; Alfieri S; Doglioni C; Kleger A; Capurso G; Sette C
Cell Rep Med; 2024 Feb; 5(2):101411. PubMed ID: 38325381
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of miR-429 as a novel serum biomarker for pancreatic ductal adenocarcinoma and analysis its tumor suppressor function and target genes.
Huang WT; Lin TS; Wu JY; Hong JM; Chen YL; Qiu FN
Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4638-4653. PubMed ID: 35856354
[TBL] [Abstract] [Full Text] [Related]
